• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Kit表达和表皮生长因子受体基因扩增对非小细胞肺癌患者生存的相对影响

Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer.

作者信息

Xiao Hui, Wang Juan, Liu Yanan, Li Li

机构信息

Department of Laboratory Medicine, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, P.R. China.

出版信息

Oncol Lett. 2014 Aug;8(2):582-588. doi: 10.3892/ol.2014.2173. Epub 2014 May 23.

DOI:10.3892/ol.2014.2173
PMID:25013472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4081302/
Abstract

c-Kit and epidermal growth factor receptor (EGFR) have critical roles in cell proliferation and differentiation in patients with non-small cell lung cancer (NSCLC). The present study aimed to investigate the prognostic impact of c-Kit and/or EGFR expression in tumor tissue samples from 146 patients with NSCLC. c-Kit expression was analyzed using immunohistochemistry and the expression of EGFR was assessed using fluorescence hybridization. Univariate and multivariate analyses identified that c-Kit is a significant negative prognostic factor. The expression of c-Kit was correlated with poor differentiation, pleura involvement and smoking history (P=0.043, 0.007 and 0.032, respectively). Furthermore, patients with c-Kit-positive expression were associated with a significantly lower overall survival compared with those exhibiting c-Kit-negative expression (P=0.048). The median follow-up time was 19 months post-surgery. EGFR gene amplification as a result of polysomy of chromosome 7 was found to be negatively correlated with poor differentiation and smoking history (P=0.023 and 0.044, respectively). The findings of the present study indicate that c-Kit and EGFR expression is a strong, independent, negative prognostic factor in NSCLC.

摘要

c-Kit和表皮生长因子受体(EGFR)在非小细胞肺癌(NSCLC)患者的细胞增殖和分化中起关键作用。本研究旨在调查c-Kit和/或EGFR表达对146例NSCLC患者肿瘤组织样本的预后影响。采用免疫组织化学分析c-Kit表达,使用荧光杂交评估EGFR表达。单因素和多因素分析确定c-Kit是一个显著的负性预后因素。c-Kit的表达与低分化、胸膜受累和吸烟史相关(分别为P = 0.043、0.007和0.032)。此外,与c-Kit阴性表达患者相比,c-Kit阳性表达患者的总生存期显著更低(P = 0.048)。术后中位随访时间为19个月。发现7号染色体多体导致的EGFR基因扩增与低分化和吸烟史呈负相关(分别为P = 0.023和0.044)。本研究结果表明,c-Kit和EGFR表达是NSCLC中一个强大的、独立的负性预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/f231fecc7f78/OL-08-02-0582-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/c3bbdfd1ec67/OL-08-02-0582-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/5db4dfa6c76c/OL-08-02-0582-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/f231fecc7f78/OL-08-02-0582-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/c3bbdfd1ec67/OL-08-02-0582-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/5db4dfa6c76c/OL-08-02-0582-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d03/4081302/f231fecc7f78/OL-08-02-0582-g02.jpg

相似文献

1
Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer.c-Kit表达和表皮生长因子受体基因扩增对非小细胞肺癌患者生存的相对影响
Oncol Lett. 2014 Aug;8(2):582-588. doi: 10.3892/ol.2014.2173. Epub 2014 May 23.
2
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.非小细胞肺癌中表皮生长因子受体的蛋白过表达和基因扩增:四种市售抗体的免疫组织化学和荧光原位杂交研究比较。
Lung Cancer. 2010 Jun;68(3):375-82. doi: 10.1016/j.lungcan.2009.07.014. Epub 2009 Aug 26.
3
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.MET、IGF-1、IGF1R表达及EGFR突变对非小细胞肺癌患者生存的影响。
PLoS One. 2017 Jul 25;12(7):e0181527. doi: 10.1371/journal.pone.0181527. eCollection 2017.
4
Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.手术切除的日本肺癌中表皮生长因子受体基因扩增
Lung Cancer. 2009 Jun;64(3):295-300. doi: 10.1016/j.lungcan.2008.10.005. Epub 2008 Dec 5.
5
[The expression of programmed death receptor 1 in non-small cell lung cancer and its clinicopathological features and prognosis showed a connection with epidermal growth factor receptor gene mutations].程序性死亡受体1在非小细胞肺癌中的表达及其临床病理特征和预后与表皮生长因子受体基因突变存在关联
Zhonghua Zhong Liu Za Zhi. 2017 Jun 23;39(6):419-423. doi: 10.3760/cma.j.issn.0253-3766.2017.06.004.
6
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.非小细胞肺癌中表皮生长因子受体基因、蛋白与吉非替尼敏感性
J Natl Cancer Inst. 2005 May 4;97(9):643-55. doi: 10.1093/jnci/dji112.
7
Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.表皮生长因子受体基因扩增预示着手术切除的非腺癌肺癌患者的预后更差。
Clin Lung Cancer. 2019 Jan;20(1):7-12.e1. doi: 10.1016/j.cllc.2018.06.003. Epub 2018 Jun 27.
8
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.吉非替尼治疗的非小细胞肺癌患者中7号染色体多体性的预后价值。
J Thorac Oncol. 2007 May;2(5):414-22. doi: 10.1097/01.JTO.0000268675.02744.b0.
9
Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer.Janus激酶1的激活预示着非小细胞肺癌患者的预后不良。
Oncol Lett. 2017 Oct;14(4):3959-3966. doi: 10.3892/ol.2017.6690. Epub 2017 Aug 1.
10
High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.高 MET 拷贝数和 MET 过表达:非小细胞肺癌患者的不良预后。
Histol Histopathol. 2012 Feb;27(2):197-207. doi: 10.14670/HH-27.197.

引用本文的文献

1
Expression and Purification of Human Stem Cell Factor and Its Effect on the Growth of A549 Cells.人干细胞因子的表达、纯化及其对A549细胞生长的影响
Protein J. 2025 Jun 2. doi: 10.1007/s10930-025-10273-w.
2
Exosome regulation of immune response mechanism: Pros and cons in immunotherapy.外泌体对免疫反应机制的调节:免疫治疗中的利弊
Bioact Mater. 2023 Oct 4;32:124-146. doi: 10.1016/j.bioactmat.2023.09.018. eCollection 2024 Feb.
3
Genetic alteration profile of -mutant resected IIB-IIIA stage NSCLC and correlation to clinical outcomes.

本文引用的文献

1
PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.PBK/TOPK 在非小细胞肺癌中的表达:与 Ki67 和 p53 表达的相关性及其预后意义。
Histopathology. 2013 Nov;63(5):696-703. doi: 10.1111/his.12215. Epub 2013 Sep 11.
2
Prognostic values of VEGF and IL-8 in malignant pleural effusion in patients with lung cancer.VEGF 和 IL-8 在肺癌恶性胸腔积液患者中的预后价值。
Biomarkers. 2013 Aug;18(5):386-90. doi: 10.3109/1354750X.2013.797499. Epub 2013 May 20.
3
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.
-突变型IIB-IIIA期非小细胞肺癌切除标本的基因改变图谱及其与临床结局的相关性。
Transl Lung Cancer Res. 2019 Dec;8(6):838-846. doi: 10.21037/tlcr.2019.10.19.
4
Predictive and prognostic value of phosphorylated c-KIT and PDGFRA in advanced non-small cell lung cancer harboring ALK fusion.磷酸化c-KIT和PDGFRA在携带ALK融合的晚期非小细胞肺癌中的预测和预后价值
Oncol Lett. 2019 Mar;17(3):3071-3076. doi: 10.3892/ol.2019.9972. Epub 2019 Jan 25.
5
lincROR influences the stemness and crizotinib resistance in EML-ALK non-small-cell lung cancer cells.长链非编码RNA ROR影响EML-ALK非小细胞肺癌细胞的干性及对克唑替尼的耐药性。
Onco Targets Ther. 2018 Jun 22;11:3649-3657. doi: 10.2147/OTT.S165290. eCollection 2018.
6
Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.手术切除的小细胞肺癌中受体酪氨酸激酶、MED12和转化生长因子-βⅡ型受体的免疫组化分析,以及c-kit作为预后标志物的潜力
Oncotarget. 2017 Jun 13;8(24):39711-39726. doi: 10.18632/oncotarget.14410.
7
Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.源自肺腺癌的球状体细胞中存在胚胎干细胞样特征和上皮-间质转化特征的证据。
Tumour Biol. 2016 Sep;37(9):11843-11859. doi: 10.1007/s13277-016-5041-y. Epub 2016 Apr 5.
8
Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.CD5和CD117表达在胸部肿瘤中的鉴别诊断价值:一项对1465例非小细胞肺癌病例的大规模研究
Diagn Pathol. 2015 Dec 8;10:210. doi: 10.1186/s13000-015-0441-7.
9
Mast cell exosomes promote lung adenocarcinoma cell proliferation - role of KIT-stem cell factor signaling.肥大细胞外泌体促进肺腺癌细胞增殖 - KIT-干细胞因子信号的作用。
Cell Commun Signal. 2014 Oct 14;12:64. doi: 10.1186/s12964-014-0064-8.
肿瘤 VEGF:VEGFR2 自分泌正反馈环触发肺癌血管生成。
J Clin Invest. 2013 Apr;123(4):1732-40. doi: 10.1172/JCI65385.
4
Comparison of immunohistology using pan-CK and EMA in the diagnosis of lymph node metastasis of gastric cancer, particularly micrometastasis and isolated tumor cells.使用广谱细胞角蛋白(pan-CK)和上皮膜抗原(EMA)进行免疫组织化学检查在胃癌淋巴结转移诊断中的比较,尤其是微转移和孤立肿瘤细胞的诊断。
Oncol Lett. 2013 Mar;5(3):768-772. doi: 10.3892/ol.2012.1078. Epub 2012 Dec 14.
5
Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women.三阴性乳腺癌与马来西亚女性的表皮生长因子受体(EGFR)、细胞角蛋白5/6(CK5/6)和原癌基因c-KIT表达有关。
BMC Clin Pathol. 2012 Sep 26;12:18. doi: 10.1186/1472-6890-12-18.
6
Utility of a CEA, CD15, calretinin, and CK5/6 panel for distinguishing between mesotheliomas and pulmonary adenocarcinomas in clinical practice.CEA、CD15、钙视网膜蛋白和 CK5/6 联合检测在临床实践中鉴别间皮瘤和肺腺癌的价值。
Am J Surg Pathol. 2012 Oct;36(10):1503-8. doi: 10.1097/PAS.0b013e31825d5371.
7
The 7th lung cancer TNM classification and staging system: Review of the changes and implications.第七版肺癌TNM分类及分期系统:变化与影响综述
World J Radiol. 2012 Apr 28;4(4):128-34. doi: 10.4329/wjr.v4.i4.128.
8
Awareness and knowledge of breast cancer and mammography among a group of Malaysian women in Shah Alam.莎阿南一群马来西亚女性对乳腺癌及乳房X光造影的认知与了解
Asian Pac J Cancer Prev. 2011;12(10):2531-8.
9
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
10
CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma.CD117、Ki-67和p53可预测神经内分泌癌的生存率,但对小细胞肺癌亚组无效。
Tumour Biol. 2011 Feb;32(1):107-11. doi: 10.1007/s13277-010-0104-y. Epub 2010 Nov 8.